AI assistant
Sending…
CVS HEALTH Corp — Director's Dealing 2018
Mar 2, 2018
29875_dirs_2018-03-02_6f68a10e-bcce-4233-b3f2-51c27778b0b1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2018-02-28
Reporting Person: Denton David M (EVP and CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-02-28 | Common Stock | A | 5315 | $67.73 | Acquired | 23715.99 | Direct |
| 2018-02-28 | Common Stock | F | 1613 | $67.73 | Disposed | 22102.99 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock (restricted) | 114041 | Direct |
| ESOP Common Stock | 1734.9293 | Indirect |
Footnotes
F1: Consists of stock awarded at market price pursuant to Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan.
F2: Surrender of shares in payment of withholding taxes due upon the vesting of a stock award under the Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan.
More from CVS HEALTH Corp
Registration Form
2026
May 22
Registration Form
2026
May 22
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 7
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3